ResMed Announces Participation in the Citi Healthcare Conference
February 16, 2022 09:00 ET
|
ResMed Inc.
SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Citi Healthcare...
ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer
February 01, 2022 09:00 ET
|
ResMed Inc.
Tyagi brings over 25 years’ IT and leadership experience from ADP, American Express, Amazon, Microsoft, and IBMCurrent CTO and SaaS President Bobby Ghoshal now transitions to SaaS full-time SAN...
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022
January 27, 2022 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 12%, operating profit up 12%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at...
ResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022
January 06, 2022 16:05 ET
|
ResMed Inc.
SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2022 on...
ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
January 03, 2022 09:00 ET
|
ResMed Inc.
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on...
ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
December 30, 2021 09:00 ET
|
ResMed Inc.
SAN DIEGO, Dec. 30, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the Goldman Sachs 14th Annual Healthcare CEOs...
ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors
November 19, 2021 09:00 ET
|
ResMed Inc.
Tan is vice president and managing director of Microsoft’s Health and Life Science R&D Hernandez is Google’s head of clinical research, health economics, and outcomes researchBoth leaders’ digital...
ResMed Announces Participation in the Credit Suisse 30th Annual Healthcare Conference
November 03, 2021 09:00 ET
|
ResMed Inc.
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Credit Suisse 30th...
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022
October 28, 2021 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 20%, operating profit up 21%, non-GAAP operating profit up 18% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at...
ResMed to Report First Quarter Fiscal 2022 Earnings on October 28, 2021
October 07, 2021 16:05 ET
|
ResMed Inc.
SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2022 on Thursday,...